Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Long-Term Debt Repayments (2019)

Updated

Reviva Pharmaceuticals Holdings' Long-Term Debt Repayments came in at -$363,436 for Q3 2019.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Long-Term Debt Repayments (2019) Analysis & Trends

For FY2018, Reviva Pharmaceuticals Holdings' Long-Term Debt Repayments was $363,436.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 1.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 19.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2019 -363,436.00
Feb 28, 2019 363,436.00
API Access

Reviva Pharmaceuticals Holdings Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=RVPH&period=max&api_key=YOUR_API_KEY